Schwartz Jeffrey Lawrence 4
4 · SpringWorks Therapeutics, Inc. · Filed May 22, 2020
Insider Transaction Report
Form 4
Schwartz Jeffrey Lawrence
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2020-05-20+7,464→ 7,464 totalExercise: $38.03Exp: 2030-05-20→ Common Stock (7,464 underlying)
Footnotes (1)
- [F1]This option shall vest in full on the earlier of (1) May 20, 2021 or (2) the next annual meeting of stockholders, subject to continued service to the Issuer on each vesting date.